½Ã½ºÅÛ °³¼±À» ÅëÇÑ ÇÙÀÇÇÐ °Ë»ç½ÇÀÇ °ø°£ ¼±·®·ü °¨¼Ò¹æ¾È
Solution to Decrease Spatial Dose Rate in Laboratory of Nuclear Medicine through System Improvement

Çѱ¹ÀÇ·áÁúÇâ»óÇÐȸÁö 2014³â 20±Ç 1È£ p.60 ~ p.73

¹®Àç½Â(Moon Jae-Seung) - °¡Å縯´ëÇб³ ¼ººó¼¾Æ®º´¿ø ÇÙÀÇÇаú
½Å¹Î¿ë(Shin Min-Yong) - °¡Å縯´ëÇб³ ¼ººó¼¾Æ®º´¿ø ÇÙÀÇÇаú
¾È¼ºÃ¶(Ahn Seong-Cheol) - °¡Å縯´ëÇб³ ¼ººó¼¾Æ®º´¿ø ÇÙÀÇÇаú
À¯¹®°ï(Yoo Mun-Gon) - °¡Å縯´ëÇб³ ¼ººó¼¾Æ®º´¿ø ÇÙÀÇÇаú
±è¼ö±Ù(Kim Su-Geun) - °¡Å縯´ëÇб³ ¼ººó¼¾Æ®º´¿ø ÇÙÀÇÇаú

Abstract

Objectives: This study aims at decreasing spatial dose rate through work improvement whilst spatial dose rate is the cause of increasing personal exposure dose which occurs in the process of handling radioisotope.

Methods: From February 2013 until July 2013, divided into "before" and "after" the improvement, spatial dose rate in laboratory of nuclear medicine was measured in gamma image room, PET/CT-1 image room, and PET/CT-2 image room as its locations. The measurement time was 08:00, 12:00 and 17:00, and SPSS 21.0 USA was opted for its statistical analysis.

Result: The spatial dose rate at distribution worktable, injection table, the entrance to the distribution room, and radioisotope storage box, which had showed high spatial dose rate, decreased by more than 43.7% a monthly average. The distribution worktable, that had showed the highest spatial dose rate in PET/CT-1 image room, dropped the rate to 42.3% as of July. The injection table and distribution worktable in the PET/CT-2 image room also showed the decline of spatial dose rate to 89% and 64.4%, respectively.

Conclusion: By improving distribution process and introducing proper radiation shielding material, we were able to drop the spatial dose rate substantially at distribution worktable, injection table, and nuclide storage box. However, taking into account of steadily increasing amount of radioisotope used, strengthening radiation related regulations, and safe utilization of radioisotope, the process of system improvement needs to be maintained through continuous monitoring.

Å°¿öµå

Laboratory of nuclear medicine, System improvement, Spatial dose rate
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå